EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency

Sophie Manoy iD, Tahlee Minto, Kalliope Demetriou, Matthew Lynch, Arthavan Selvanathan iD, Luke Jardine, Michelle Lipke, Carolyn Bursle, Anita Inwood, Jim McGill, David Coman iD

JIMD Reports · 2026-03 · 67 (2)

DOI: 10.1002/jmd2.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JIMD Reports, online erschienen am 23.02.2026. Verfasst von Sophie Manoy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Lifespan Metabolic Medicine Service, Queensland Children's Hospital Brisbane Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbonic anhydrase VA (CAVA) deficiency (OMIM 114761) is an ultra‐rare inborn error of metabolism with fewer than 20 cases described. Affected infants present in the first days of life with hyperammonaemia, lactic acidosis, ketonaemia and encephalopathy. Prenatal genetic testing can facilitate the diagnosis of subsequent affected pregnancies and permit proactive clinical management to prevent metabolic decompensation. Here we describe the clinical course of two sibling infants antenatally diagnosed with CAVA deficiency who were monitored and managed in the newborn period without decompensation. The proband, their older brother, had presented on day four of life with marked lactic acidosis, hyperammonaemia and encephalopathy requiring haemofiltration due to CAVA deficiency. His brothers were each born in a tertiary neonatal setting. They were managed with regular 3–4 hourly breastfeeds with supplementary expressed breast milk and formula top‐ups to ensure optimal nutrition. In addition, they received carglumic acid (100 mg/kg daily) for 5 days. Regular biochemical monitoring was undertaken with measurement of acid–base status and ammonia levels. In contrast to their older brother, these male siblings had unremarkable neonatal periods with no significant clinical or biochemical concerns, demonstrating that in a neonate known to be affected with CAVA deficiency, early intervention can be instituted to minimise the risk of metabolic decompensation in the neonatal period.

Schlagwörter

Stichwörter der Autor:innen

CAVA deficiencycarbonic anhydrase VA deficiencyexpectant neonatal managementinborn error of metabolism

Autor:innen und Institutionen

  • Queensland Lifespan Metabolic Medicine Service, Queensland Children's Hospital Brisbane Australia.
  • School of Medicine The University of Queensland Brisbane Australia.
  • Department of Neonatology Mater Mothers Hospital Brisbane Australia.
  • School of Nursing and Social Work The University of Queensland Brisbane Australia.
  • Department of Chemical Pathology The Royal Brisbane and Women's Hospital Brisbane Australia.

ORCID-Profile: Sophie Manoy, Arthavan Selvanathan, David Coman

Zitieren

APA

Manoy, S., Minto, T., Demetriou, K., Lynch, M., Selvanathan, A., Jardine, L., Lipke, M., Bursle, C., Inwood, A., McGill, J., & Coman, D. (2026). Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency. JIMD Reports, 67(2). https://doi.org/10.1002/jmd2.70076

Vancouver

Manoy S, Minto T, Demetriou K, Lynch M, Selvanathan A, Jardine L, et al. Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency. JIMD Reports. 2026;67(2). doi:10.1002/jmd2.70076

BibTeX
@article{Manoy2026,
  author = {Manoy, Sophie and Minto, Tahlee and Demetriou, Kalliope and Lynch, Matthew and Selvanathan, Arthavan and Jardine, Luke and Lipke, Michelle and Bursle, Carolyn and Inwood, Anita and McGill, Jim and Coman, David},
  title = {Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency},
  journal = {JIMD Reports},
  year = {2026},
  volume = {67},
  number = {2},
  doi = {10.1002/jmd2.70076}
}
Kostenlos starten →